These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12465151

  • 1. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D.
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [Abstract] [Full Text] [Related]

  • 2. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Bashkin A, Mandelboim M, Litinsky I, Comaheshter D, Levartovsky D, Mendelson E, Wigler I, Caspi D, Paran D.
    Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
    [Abstract] [Full Text] [Related]

  • 3. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 4. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [Abstract] [Full Text] [Related]

  • 6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 7. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [Abstract] [Full Text] [Related]

  • 8. Influenza vaccination of patients with systemic lupus erythematosus.
    Mercado U, Acosta H, Avendaño L.
    Rev Invest Clin; 2004 Oct; 56(1):16-20. PubMed ID: 15144037
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
    Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL.
    Acta Reumatol Port; 2009 Oct; 34(3):498-502. PubMed ID: 19820674
    [Abstract] [Full Text] [Related]

  • 10. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 11. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.
    Buxton JA, Skowronski DM, Ng H, Marion SA, Li Y, King A, Hockin J.
    J Infect Dis; 2001 Jul 15; 184(2):188-91. PubMed ID: 11424016
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 15; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 13. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003 Jul 15; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

  • 14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 15. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M.
    Gerontology; 2007 Oct 25; 53(6):411-8. PubMed ID: 17975317
    [Abstract] [Full Text] [Related]

  • 16. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium.
    Arch Intern Med; 2008 Dec 08; 168(22):2405-14. PubMed ID: 19064822
    [Abstract] [Full Text] [Related]

  • 17. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 08; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 18. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study.
    Kositanont U, Kanyok R, Wasi C, Wongsurakiat P, Suthamsmai T, Maranetra N.
    J Med Assoc Thai; 2004 Aug 08; 87(8):964-9. PubMed ID: 15471303
    [Abstract] [Full Text] [Related]

  • 19. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 20. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.